MK0686 in Postsurgery Dental Pain (0686-002)

Pain, Postoperative Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00533403
• Other study ID #: 0686-002
• Secondary ID: 2007_617
• Status: Completed
• Phase: Phase 2
• First received: September 19, 2007
• Last updated: June 25, 2015
• Start date: July 2004
• Est. completion date: November 2004

Study information

• Verified date: June 2015
• Source: Merck Sharp & Dohme Corp.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Interventional

Clinical Trial Summary

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 114
• Est. completion date: November 2004
• Est. primary completion date: November 2004
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed

• Patients must agree to remain in the clinic for 24 hours after surgery

Exclusion Criteria:

• Patient has history of heart disease, asthma, pulmonary disease

• Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Pain, Postoperative

Intervention

Drug:
• MK0686

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Merck Sharp & Dohme Corp.